Chung EYM - Search Results

1

Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatment.

Chung EYM, Wang YM, Keung K, Hu M, McCarthy H, Wong G, Kairaitis L, Bose B, Harris DCH, Alexander SI. Chung EYM, et al. Front Immunol. 2022 Nov 2;13:1036249. doi: 10.3389/fimmu.2022.1036249. eCollection 2022. Front Immunol. 2022. PMID: 36405681 Free PMC article. Review.

2

Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis.

Chung EYM, Palmer SC, Natale P, Krishnan A, Cooper TE, Saglimbene VM, Ruospo M, Au E, Jayanti S, Liang A, Jie Deng DJ, Chui J, Higgins GY, Tong A, Wong G, Teixeira-Pinto A, Hodson EM, Craig JC, Strippoli GFM. Chung EYM, et al. Am J Kidney Dis. 2021 Dec;78(6):804-815. doi: 10.1053/j.ajkd.2021.07.003. Epub 2021 Aug 5. Am J Kidney Dis. 2021. PMID: 34364906 Free PMC article.

3

Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis.

Bose B, Chung EYM, Hong R, Strippoli GFM, Johnson DW, Yang WL, Badve SV, Palmer SC. Bose B, et al. Among authors: chung eym. J Nephrol. 2022 May;35(4):1159-1170. doi: 10.1007/s40620-022-01268-2. Epub 2022 Feb 23. J Nephrol. 2022. PMID: 35199314 Free PMC article.

4

Interleukin-33 Exacerbates IgA Glomerulonephritis in Transgenic Mice Overexpressing B Cell Activating Factor.

Wang YM, Shaw K, Zhang GY, Chung EYM, Hu M, Cao Q, Wang Y, Zheng G, Wu H, Chadban SJ, McCarthy HJ, Harris DCH, Mackay F, Grey ST, Alexander SI. Wang YM, et al. Among authors: chung eym. J Am Soc Nephrol. 2022 May;33(5):966-984. doi: 10.1681/ASN.2021081145. Epub 2022 Apr 6. J Am Soc Nephrol. 2022. PMID: 35387873 Free PMC article.

5

Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics.

Chung EYM, Trinh K, Li J, Hahn SH, Endre ZH, Rogers NM, Alexander SI. Chung EYM, et al. Front Cardiovasc Med. 2022 May 20;9:868658. doi: 10.3389/fcvm.2022.868658. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35669475 Free PMC article. Review.

6

Predictive Models for Recurrent Membranous Nephropathy After Kidney Transplantation.

Chung EYM, Blazek K, Teixeira-Pinto A, Sharma A, Kim S, Lin Y, Keung K, Bose B, Kairaitis L, McCarthy H, Ronco P, Alexander SI, Wong G. Chung EYM, et al. Transplant Direct. 2022 Aug 4;8(9):e1357. doi: 10.1097/TXD.0000000000001357. eCollection 2022 Sep. Transplant Direct. 2022. PMID: 35935023 Free PMC article.

7

Oxalate nephropathy in ataxia telangiectasia - A case report.

Perera LR, Chung EYM, Roxburgh S. Perera LR, et al. Among authors: chung eym. Nephrology (Carlton). 2023 Aug;28(8):468-469. doi: 10.1111/nep.14173. Epub 2023 May 16. Nephrology (Carlton). 2023. PMID: 37191056 No abstract available.

8

Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?

Chung EYM, Badve SV, Heerspink HJL, Wong MG. Chung EYM, et al. Nephrology (Carlton). 2023 Feb;28(2):97-108. doi: 10.1111/nep.14130. Epub 2022 Nov 15. Nephrology (Carlton). 2023. PMID: 36350038 Free PMC article. Review.

9

Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.

Chung EY, Ruospo M, Natale P, Bolignano D, Navaneethan SD, Palmer SC, Strippoli GF. Chung EY, et al. Cochrane Database Syst Rev. 2020 Oct 27;10(10):CD007004. doi: 10.1002/14651858.CD007004.pub4. Cochrane Database Syst Rev. 2020. PMID: 33107592 Free PMC article.

10

A Case Report of Henoch-Schonlein Purpura and IgA Nephropathy Associated With Rivaroxaban.

Chung EY, Chen J, Roxburgh S. Chung EY, et al. Nephrology (Carlton). 2018 Mar;23(3):289-290. doi: 10.1111/nep.13058. Nephrology (Carlton). 2018. PMID: 29461002 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page